Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 22, 2023
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
Swayampakula Ramakanth Maintained (XFOR) at Strong Buy with Decreased Target to $3 on, Mar 22nd, 2023
Swayampakula Ramakanth of HC Wainwright & Co., Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Decreased Target from $5 to $3 on, Mar 22nd, 2023.
Swayampakula has made no other calls on XFOR in the last 4 months.
There is 1 other peer that has a rating on XFOR. Out of the 1 peers that are also analyzing XFOR, 0 agree with Swayampakula's Rating of Hold.
This is the rating of the analyst that currently disagrees with Swayampakula
- Edward Tenthoff of "Piper Sandler" Initiated at Buy and Held Target at $3 on, Monday, December 12th, 2022
